http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11191968-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42053d4f517feab5a9bb4b92ece8256e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3615
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36139
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36175
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2016-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_796ec8b212b2f1f6cd888447d5fe1820
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd6fa645bd3d00549f8e2f40b6bdb844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74a75aa23db59b7a156b49b579040f5b
publicationDate 2021-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11191968-B1
titleOfInvention Movement disorder therapy system, devices and methods of tuning
abstract The present invention relates to methods for tuning treatment parameters in movement disorder therapy systems. The present invention further relates to a system for screening patients to determine if they are viable candidates for certain therapy modalities. The present invention still further provides methods of quantifying movement disorders for the treatment of patients who exhibit symptoms of such movement disorders including, but not limited to, Parkinson's disease and Parkinsonism, Dystonia, Chorea, and Huntington's disease, Ataxia, Tremor and Essential Tremor, Tourette Syndrome, and the like. The present invention yet further relates to methods of tuning a therapy device using objective quantified movement disorder symptom data acquired by a movement disorder diagnostic device to allow a clinician, technician or physician to determine the therapy setting or parameters to be provided to the subject via his or her therapy device.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11422043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701293-B2
priorityDate 2011-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7231254-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6368813-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008097553-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014153794-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006015153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005021104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013123684-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007255118-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5833709-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5716377-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9662502-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008312513-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004249422-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010228314-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014336539-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007179534-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014276130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8391986-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7242984-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006058855-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006234309-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008119900-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006212097-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7010351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8187209-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7236831-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006033039-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7305268-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208787-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008071150-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007032834-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9794626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412483216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458403899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449441181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451110572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID224478

Total number of triples: 74.